This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Universitè Laval, Endorecherche, Inc., Valorisation Recherche Hscm, Limited Partnership. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Québec, CA (2010 - 2017)
- Quebec, CA (2014 - 2021)
Company Filing History:
4 out of 304 
1 out of 80 
1 out of 4 Years Active: 2010-2025
Title: The Innovations of Inventor René Maltais in Cancer Treatment
Introduction
René Maltais, an inventive mind hailing from Québec, Canada, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of three patents to his name, Maltais is recognized for his groundbreaking work in developing aminosteroid derivatives and 1,2,3,4-tetrahydroisoquinoline derivatives, particularly focusing on cancer treatments.
Latest Patents
Maltais's latest patents encompass essential advancements in medical chemistry. The first patent details "Aminosteroid derivatives and process for producing same," where Estrane-based and Androstane-based aminosteroid derivatives are described. The patent outlines piperazinyl-steroid compounds that exhibit cytotoxicity against various cancer cell lines, highlighting a promising avenue for future pharmaceutical formulations.
His second patent, "Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases," covers compounds that inhibit steroid sulfatase (STS) and act as selective estrogen receptor modulators (SERMs). These compounds demonstrate potential efficacy in treating hormone-related medical conditions, including breast cancer, prostate cancer, and other significant diseases tied to hormone regulation.
Career Highlights
René Maltais has been influential in his career, working with notable institutions such as Université Laval and Endorecherche, Inc. His academic and professional environments have fostered his innovative spirit and have played a critical role in his patent filings and advancements in medical treatments.
Collaborations
Throughout his journey as an inventor, Maltais has collaborated with esteemed colleagues including Donald Poirier and Fernand Labrie. These partnerships have likely enhanced his research outcomes and contributed to the prolific nature of his innovations in the pharmaceutical field.
Conclusion
René Maltais continues to be a formidable presence in medical research, with his patents paving the way for new treatments targeting cancer and other hormone-dependent conditions. His work exemplifies how innovative thinking and collaboration can lead to advancements that have the potential to save lives and change the landscape of modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile